Recent events
Recent events tied to this brand in public sources.
Back to profile2 entries
2021
QIAGEN and DiaSorin launch LIAISON LymeDetect Assay
QIAGEN and DiaSorin announced the launch of the LIAISON LymeDetect Assay for markets accepting the CE mark. The assay is designed to aid detection of early Lyme borreliosis on LIAISON analyzer systems.
2020
DiaSorin and MeMed partner to commercialize MeMed BV
DiaSorin and MeMed announced a strategic partnership under which DiaSorin obtained rights to commercialize MeMed BV on its LIAISON analyzer family. The companies said the test would be made available on more than 5,000 installed LIAISON XL and XS platforms worldwide.